Canine leishmaniosis on Favignana Island: a prospective observational study on infection dynamics, clinical outcomes and field safety in dogs receiving both vaccination (LETIFEND®) and an antifeeding collar (SCALIBOR®)
Valentina Foglia Manzillo, Gaetano Oliva, Germano Castelli, Federica Bruno, Roberto Rosenthal, Serena Montagnaro, Ines Balestrino, Claudia La Rocca, Liliana Colombo, Manuela Gizzarelli · 2026
Read Canine leishmaniosis on Favignana Island: a prospective observational study on infection dynamics, clinical outcomes and field safety in dogs receiving both vaccination (LETIFEND®) and an antifeeding collar (SCALIBOR®) by Valentina Foglia Manzillo, Gaetano Oliva, Germano Castelli, Federica Bruno, Roberto Rosenthal, Serena Montagnaro, Ines Balestrino, Claudia La Rocca, Liliana Colombo, Manuela Gizzarelli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13418434.txt.
Description
Valentina Foglia Manzillo and colleagues tested combined vaccination and a repellent collar against canine leishmaniosis on Favignana Island, Italy, in a 2026 field study. The sandfly-borne disease threatens dogs and people in endemic areas, yet field proof for using both protections together was thin.
Of 154 screened dogs, about 12 percent already carried the parasite. Among 62 enrolled negative dogs followed for two years, only two fell ill while nine more showed low antibody levels without symptoms. Island vets gain field evidence that the combined shield holds up well across two transmission seasons.
Catalog record
| CREATOR | Valentina Foglia Manzillo, Gaetano Oliva, Germano Castelli, Federica Bruno, Roberto Rosenthal, Serena Montagnaro, Ines Balestrino, Claudia La Rocca, Liliana Colombo, Manuela Gizzarelli |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |